Ethylene Oxide Residues and Aeration: Reading ISO 10993-7 Limits

Ethylene Oxide Residues and Aeration: Reading ISO 10993-7 Limits

Quick summary: ISO 10993-7 sets the allowable limits for residual ethylene oxide and ethylene chlorohydrin left on a device after EO sterilization, and describes how those residues are measured before a device is released. For a clinic or long-term care buyer, it explains why two suppliers can both say "EO sterilized" and still not be offering the same thing — one can produce a release record, the other cannot.

A dental office opens a fresh carton of gauze sponges. A long-term care home receives a pallet of dressings. A laboratory restocks foam swabs. Somewhere on that packaging, in small print, is a line most buyers skim past: sterilized by ethylene oxide. The words describe a process that took place weeks earlier, in a chamber several provinces away, and they carry a legal and clinical meaning that a purchase order does not capture.

Ethylene oxide is used for a simple reason. It penetrates porous packaging, works at temperatures that do not melt plastic, and suits the heat-sensitive materials that steam would destroy. The same properties that make it useful also make it persistent: it can remain on a device after the cycle ends. ISO 10993-7 exists to put numbers around that persistence.

Why Do Ethylene Oxide Residues Matter to a Clinic Buyer?

When EO meets chloride ions on or inside a device, it can form ethylene chlorohydrin. When it meets water, it can form ethylene glycol. Steris AST, which operates contract sterilization facilities, describes all three as residues that may be found after processing and notes that they can be harmful to the end user or patient if the device is released without meeting the limits in the standard.

That framing matters more than it first appears. A residue is not a manufacturing defect that a visual inspection would catch. Packaging arrives intact, labels are legible, the pouch seal is even, and the sponges look like sponges. The question of residue lives entirely in documentation and in the validation file of the company that ran the cycle.

Occupational exposure is a second, separate concern. A study published in the Journal of Occupational and Environmental Medicine looked at working conditions and health effects of ethylene oxide exposure at hospital sterilization sites, a reminder that the gas is a workplace hazard in the facilities that use it in bulk, not in the clinic that receives the finished box.

What Limits Does ISO 10993-7 Actually Set?

The standard sorts devices by contact duration and assigns an allowable limit to each category. A device that contacts the patient for less than 24 hours is a limited-exposure device. Between 24 hours and 30 days, it is a prolonged-exposure device. Beyond 30 days, it is permanent. The limits scale with exposure time, and the summary table below reflects the values published by Steris AST from the AAMI/ISO 10993-7 standard.

Two practical points sit underneath that table. First, special device categories carry their own limits, which is why blood oxygenators and blood cell separators appear separately rather than being folded into the general durations. Second, the standard is not the only route to a release decision: an alternative approach based on a toxicological risk assessment of the specific device and its use can be used to derive product-specific limits, which is how many modern device families are cleared.

What follows for a buyer is a question worth asking of any supplier of EO-sterilized consumables: which category does this product fall into, and which limit was applied at release? A supplier that cannot answer has not necessarily done anything wrong — but the buyer has no way to know.

How Long Does Aeration Take After an EO Cycle?

Aeration is the name for the stage that removes residual gas after the sterilizing portion of the cycle is complete. Steris AST describes two forms. In-chamber aeration keeps heat in the chamber after the gas has been removed, sometimes by raising the processing temperature set point or adding a moisture conditioning phase. Extended aeration moves the load into a heated aeration cell to continue off-gassing.

The industry average for a typical aeration time is six to twenty-four hours, but that number is a description of common practice rather than a rule. Some devices require no heated aeration at all; others need considerably more than a day. The figure is established during validation for the specific device, load and packaging combination, which is exactly why a supplier's validation file is more informative than a sales sheet.

Published research supports the idea that aeration conditions are not interchangeable. A study in the Journal of Orthopaedic Science examined how aeration, storage and rinsing conditions influenced residual ethylene oxide in freeze-dried bone allograft, and found the variables made a measurable difference. Separate work in the Journal of Biomedical Materials Research reported residue levels in medical-grade tubing and their effect in an in-vitro biological system. The pattern across both is consistent: how a load is aerated and stored changes what remains on it.

For the consumables a clinic actually buys — Class 4 dual indicator sterilization pouches and sterilization roll for instrument sets — the packaging is part of the equation rather than an afterthought. A sterile barrier system has to let the sterilizing agent in and keep microorganisms out, and its permeability is one of the properties that governs how quickly a load can be aerated and how long it can be stored. That balance is described in ISO 11607-1, and the seal that closes the system is verified with methods such as ASTM F88 and ASTM F2096.

Which Sterilization Modality Sits Behind Your Supplies?

Ethylene oxide is one of four modalities a Canadian clinic is likely to encounter. Steam under pressure remains the default for reusable instruments processed in-house, and is covered by ISO 17665. Ethylene oxide, covered by ISO 11135, handles heat- and moisture-sensitive items. Radiation, covered by ISO 11137, is used at industrial scale for single-use devices. A fourth family, covering sterilizing agents not addressed by the other parts, is covered by ISO 14937.

The reason a buyer should care which modality was used is that the residual and packaging questions follow from it. EO brings residue limits and aeration. Radiation brings dose-setting and material effects. Steam brings cycle monitoring and water quality. An article that compares the four modalities in more detail is here in our guide to ISO 17665, ISO 11135 and ISO 11137, and the bioburden and sterility testing that sits in front of all four is covered in our explainer on ISO 11737-1 and -2.

What Should a Clinic Ask a Supplier For?

Residue compliance is a documentation exercise at the buyer's end. Five questions cover most of it.

• Which modality? EO, steam, radiation or another agent. The label should say, and the answer should match across shipments.
• Which edition of the standard? ISO 10993-7 has been revised, and a supplier should be able to name the edition its release testing followed.
• Which exposure category? Limited, prolonged or permanent. This determines the limit applied to the product you are buying.
• What does the release record show? A batch reference that traces to a validated cycle, with a residue result where the standard calls for one.
• Who ran the validation? An in-house facility, a contract sterilizer or the device manufacturer. Contract facilities publish their own process summaries, which makes them easy to verify.

Two supporting documents are worth keeping alongside the purchase order. A risk management file prepared under ISO 14971 tells you how the supplier thought about the failure modes on the device, including residuals; our note on ISO 14971 risk files explains what a clinic can reasonably request. Infection prevention guidance from Public Health Ontario's reprocessing checklist covers the in-clinic side: how instruments are packed, monitored and stored after they come out of your own autoclave.

If you are comparing suppliers across a multi-site order, the wholesale and multi-site ordering desk is where lot documentation and delivery schedules are agreed in one place, and our sterilization monitoring range collects the indicators, tape and pouches that support the records side of the programme. Clinics that want to see how a biological indicator behaves in their own autoclave before committing to a quarterly order can start with the biological indicator 5-pack trial at CA $12.99 with shipping included.

References and standards cited

1. ISO 10993-7:2026 Biological evaluation of medical devices — Part 7: Ethylene oxide sterilization residuals (link checked 21 September 2026)
2. ISO 10993-7:2008 Biological evaluation of medical devices — Part 7: Ethylene oxide sterilization residuals (link checked 21 September 2026)
3. ISO 11135 Sterilization of health-care products — Ethylene oxide — Requirements for the development, validation and routine control of a sterilization process for medical devices (link checked 21 September 2026)
4. ISO 11737-1 and -2: Bioburden and Sterility Testing Explained (link checked 21 September 2026)
5. ISO 14971 Risk Files: What Clinic Buyers Can Ask Suppliers For (link checked 21 September 2026)
6. ISO 11607-1 Packaging for terminally sterilized medical devices — Part 1: Requirements for materials, sterile barrier systems and packaging systems (link checked 21 September 2026)
7. ASTM F88/F88M Standard Test Method for Seal Strength of Flexible Barrier Materials (link checked 21 September 2026)
8. ASTM F2096 Standard Practice for Detecting Gross Leaks in Packaging by Internal Pressurization (link checked 21 September 2026)
9. ASTM F1249 Standard Test Method for Water Vapor Transmission Rate Through Plastic Film and Sheeting (link checked 21 September 2026)
10. Health Canada — Medical Devices Regulations (SOR/98-282) (link checked 21 September 2026)
11. Public Health Ontario — IPAC Checklist for Dental Practice: Reprocessing (link checked 21 September 2026)
12. Public Health Ontario — IPAC Checklist for Dental Practice: Core Elements (link checked 21 September 2026)
13. Canadian Centre for Occupational Health and Safety — Ethylene oxide in the workplace (link checked 21 September 2026)
14. Marais F, et al. Residual ethylene oxide in medical devices and device material. J Biomed Mater Res B Appl Biomater. 2003 (link checked 21 September 2026)
15. Influence of aeration, storage, and rinsing conditions on residual ethylene oxide in freeze-dried bone allograft. J Orthop Sci. 2002 (link checked 21 September 2026)
16. Working conditions and health effects of ethylene oxide exposure at hospital sterilization sites. J Occup Environ Med. 1999 (link checked 21 September 2026)
17. Chemical modifications of therapeutic proteins induced by residual ethylene oxide. J Pharm Sci. 2015 (link checked 21 September 2026)
18. Steris AST — Overview of ethylene oxide residuals (allowable limit summary) (link checked 21 September 2026)
19. Sterilization Modalities: ISO 17665, ISO 11135 and ISO 11137 (link checked 21 September 2026)

Related Reading

• Sterilization compliance hub — records, indicators and audits
• Seal Integrity Testing for Sterile Pouches: ASTM F88, F1929 and F1886
• Pouch vs Wrap for Cassette Sterilization
• Sterilization Monitoring Supplies for Canadian Clinics
• Class 4 dual indicator sterilization pouches, assorted sizes
• Sterilization roll, 76 mm × 50 m, heat-seal
• Biological indicator 5-pack trial, CA $12.99 with shipping included
• Wholesale and multi-site ordering desk
• free Ontario sterilization compliance log
• printable autoclave sterilization log sheet (free)

Frequently Asked Questions

What is ISO 10993-7?

ISO 10993-7 is the part of the ISO 10993 biological evaluation series that deals with residuals left on a device after ethylene oxide sterilization. It sets allowable limits for residual ethylene oxide, the ethylene chlorohydrin that forms when EO meets chloride ions, and it describes how residues are measured and how conformity is established before a device is released.

Which residue limit applies to my clinic's gauze sponges?

It depends on how long the device contacts the patient. A device in contact for less than 24 hours falls into the limited-exposure category, where the allowable limit is 4 mg of residual EO per device. Dressings and sponges left in place for more than 24 hours move into the prolonged category at 60 mg per 30 days, and implants in place for more than 30 days fall under the permanent category at 2.5 g per lifetime.

What is ethylene chlorohydrin?

Ethylene chlorohydrin (ECH) is a residue that can form when ethylene oxide comes into contact with free chloride ions, either in the device material or in the surrounding environment. It is treated separately from EO itself, with its own allowable limits: 9 mg for limited exposure, 60 mg per 30 days for prolonged exposure and 10 g per lifetime for permanent devices.

Does every sterile product need an EO residual test?

No. The limits apply to devices intended for patient contact. Products with no patient contact, such as instrument packaging or waste bags, are outside that scope. If a supplier sterilizes a patient-contact item with ethylene oxide, the release documentation is where the residue result belongs.

Is a "sterilized by ethylene oxide" line on the label enough?

The label tells you which modality was used, not whether the batch met its residue limit. A release certificate, a batch number that traces back to a validated cycle and, where applicable, a residue test result are the documents that answer the residue question. A label alone does not.

How long does aeration take after an EO cycle?

Aeration is the off-gassing stage that follows the sterilizing cycle. Steris AST describes an industry-average aeration time of six to twenty-four hours for a typical load, with some devices needing no heated aeration at all and others requiring longer. The figure is set during validation for the specific device, load and packaging configuration, not chosen from a table.

Does ethylene oxide damage the devices it sterilizes?

Residual EO and the residues it forms can react with materials, which is one reason the limits exist. Published work has looked at residue levels in medical-grade tubing and at chemically induced changes in protein-based products after EO exposure. Material compatibility is a device-specific question, and the sterilizer validation file is where it is answered.

Do Canadian clinics need to test incoming sterile stock?

Clinics are not expected to run residue assays in the treatment room. The practical duty is documentation: keep the lot numbers, keep the release paperwork, and know which of your supplies are EO-sterilized, so that a question from a patient, an inspector or a procurement auditor can be answered from a record rather than from memory.

Last updated: September 2026. CliniEco Medical is a licensed medical device establishment (MDEL #35334).